Melorheostosis

From WikiMD's Medical Encyclopedia

Revision as of 16:39, 24 February 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Melorheostosis is a rare, non-hereditary skeletal disorder characterized by irregular, flowing hyperostosis of the cortex of tubular bones. The condition was first described in 1922 by Leri and Joanny, and its name is derived from the Greek words melos (limb), rhein (to flow), and ostosis (condition of the bone).

Epidemiology

Melorheostosis affects both sexes equally and can manifest at any age, although it is typically diagnosed in early adulthood. The prevalence of the condition is estimated to be 0.9 per million.

Pathophysiology

The pathophysiology of melorheostosis is not fully understood. It is believed to be caused by a somatic mutation in the MAP2K1 gene, which leads to increased activity of the MEK1 protein and subsequent hyperostosis. The condition is not inherited but occurs sporadically.

Clinical Presentation

Patients with melorheostosis often present with pain, stiffness, and functional impairment of the affected limb. The condition can also cause deformities and contractures. Radiographically, melorheostosis is characterized by dense, flowing hyperostosis of the cortex of tubular bones, often described as "dripping candle wax" appearance.

Diagnosis

The diagnosis of melorheostosis is primarily based on clinical and radiographic findings. Computed tomography (CT) and magnetic resonance imaging (MRI) can be used to further characterize the lesion and assess the extent of the disease.

Treatment

There is currently no cure for melorheostosis. Treatment is symptomatic and may include pain management, physical therapy, and in some cases, surgery to correct deformities or contractures.

Prognosis

The prognosis of melorheostosis varies depending on the severity and extent of the disease. While the condition is not life-threatening, it can significantly impact the patient's quality of life due to pain and functional impairment.

See Also

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.